SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- diabetes -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (232)6/9/2008 9:54:19 PM
From: DewDiligence_on_SI  Respond to of 278
 
>Seen anywhere how many units can be administered per snort? I can't believe this would work.<

I haven’t paid attention to those kinds of details because I don’t think the underlying technology works well enough to form the basis of a commercial drug.

MRK, PG, NVO, and PFE have had intranasal drug-delivery collaborations with NSTK at one time or another, but none of them amounted to anything. Regards, Dew